首页> 外国专利> METHOD OF COMBINED TREATMENT OF NON-SMALL-CELL LUNG CANCER

METHOD OF COMBINED TREATMENT OF NON-SMALL-CELL LUNG CANCER

机译:非小细胞肺癌联合治疗方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to surgery, and concerns a combined treatment of non-small-cell lung cancer. That is ensured by lymphotropic chemotherapy following radical surgical intervention with extended mediastinal lymphadenectomy. For lymphotropic chemotherapy, a catheter is placed in the mediastenum, a distal portion of the catheter is inserted in the fifth intercostal space along a parasternal line on the anterior thoracic wall, and starting from 3 days after the operation, an endolymphatic guide is introduced into the catheter, which is a glucose-novocaine mixture in proportions of 100 ml of 5 % glucose and 100 ml of 0.25 % novocaine. Then, at 15 minutes, a cisplatin solution is administered drop-by-drop through the catheter in dose of 25 mg/m2.;EFFECT: method provides higher clinical effectiveness and reduced risk of non-small-cell lung cancer metastasis.;1 cl
机译:技术领域本发明涉及外科手术,并且涉及非小细胞肺癌的联合治疗。彻底的纵隔淋巴结清扫术根治性手术后,通过淋巴化疗可以确保这一点。对于淋巴化疗,将导管放置在中肋骨中,将导管的远侧部分沿着胸前壁上的胸骨旁线插入第五肋间隙,并从手术后3天开始,将内淋巴导管引入导管,它是一种葡萄糖-novocaine混合物,比例为100 ml的5%葡萄糖和100 ml的0.25%novocaine。然后,在15分钟时,以25 mg / m 2 的剂量逐滴通过导管施用顺铂溶液。细胞肺癌转移; 1 cl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号